MVMarcela González-Del Vecchio

Marcela González-Del Vecchio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcela González-Del Vecchio has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Emilio Bouza

    Department of Clinical Microbiology and Infectious Diseases; Gregorio Marañón Institute of Health Research (IiSGM); Department of Medicine, Faculty of Medicine, Complutense University. Madrid, Spain

    5 shared publications
  • Mercedes Marin

    From the *Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; †Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain; ‡Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; and §CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Madrid, Spain

    2 shared publications
  • A. Rodríguez-Borlado

    Hospital General Universitario Gregorio Marañón

    1 shared publication
  • Adoración Martín

    From the *Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain; †Facultad de Medicina, Universidad Complutense de Madrid (UCM), Madrid, Spain; ‡Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; and §CIBER de Enfermedades Respiratorias (CIBERES CD06/06/0058), Madrid, Spain

    1 shared publication
  • Ana Álvarez-Uría

    Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) , Madrid

    1 shared publication
  • Antonio Vena

    Department of Health Sciences (DISSAL) University of Genoa Genoa Italy

    1 shared publication

Latest Publications

  • Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital

    by Marcela González-Del Vecchio, María Jesús Ruíz-Serrano, Paloma Gijón, Mar Sánchez-Somolinos, Viviana de Egea, Darío García de Viedma, María Norberta Sánchez Fresneda, Emilio Bouza


  • Clinical Significance of Clostridium difficile in Children Less Than 2 Years Old

    by Marcela González-Del Vecchio, Ana Álvarez-Uria, Mercedes Marin, Luis Alcalá, Adoración Martín, Pedro Montilla, Emilio Bouza

    Background: The significance of Clostridium difficile (CD) in the stools of children 2 years old or younger remains unclear. The aim of this study was to investigate risk factors and clinical evolution of diarrheic children ≤2 years old with or without CD in their stools. Methods: From January 1, 2012 to December 31, 2013, all diarrheic stool samples received in our laboratory were screened for CD. We randomly selected diarrheic children ≤2 years old (n = 100) with an isolation of toxigenic CD in the stools and compared them with diarrheic children (n = 100) without isolation of CD. Results: Cases and controls were appropriately matched for age and sex. We found no significant differences between children with or without CD. Of the CD cases, we compared the patients receiving treatment with metronidazole (19%) versus those that were not prescribed treatment (81%), and found that patients in the first group had used more gastric acid suppressants (P = 0.02), had surgery in the last month (P = 0.03) and also presented with more days with diarrhea (P = 0.03). All the patients, including CD cases, independently of the administration of metronidazole, were cured of the diarrheic episode. Polymerase chain reaction-ribotyping performed in all CD cases showed that the most prevalent ribotype was 014 (25%). Conclusions: Our study reinforces the nonsignificance of CD in neonates and infants younger than 2 years old. Informing clinicians of CD isolates in this population promotes the use of antibiotics against CD, without evidence of a different outcome than those not receiving treatment.


  • An algorithm to diagnose influenza infection: evaluating the clinical importance and impact on hospital costs of screening with rapid antigen detection tests

    by M. González-Del Vecchio, P. Catalán, V. de Egea, A. Rodríguez-Borlado, C. Martos, B. Padilla, B. Rodríguez-Sanchez, E. Bouza

    Rapid antigen detection tests (RADTs) are immunoassays that produce results in 15 min or less, have low sensitivity (50 %), but high specificity (95 %). We studied the clinical impact and laboratory savings of a diagnostic algorithm for influenza infection using RADTs as a first-step technique during the influenza season. From January 15th to March 31st 2014, we performed a diagnostic algorithm for influenza infection consisting of an RADT for all respiratory samples received in the laboratory. We studied all the patients with positive results for influenza infection, dividing them into two groups: Group A with a negative RADT but positive reference tests [reverse transcription polymerase chain reaction (RT-PCR) and/or culture] and Group B with an initial positive RADT. During the study period, we had a total of 1,156 patients with suspicion of influenza infection. Of them, 217 (19 %) had a positive result for influenza: 132 (11 %) had an initial negative RADT (Group A) and 85 (7 %) had a positive RADT (Group B). When comparing patients in Group A and Group B, we found significant differences, as follows: prescribed oseltamivir (67 % vs. 82 %; p = 0.02), initiation of oseltamivir before 24 h (89 % vs. 97 %; p = 0.03), antibiotics prescribed (89 % vs. 67 %; p = p = 0.05), and need for supplementary oxygen (61 % vs. 47 %; p = 0.01). An influenza algorithm including RADTs as the first step improves the time of administration of proper antiviral therapy, reduces the use of antibiotics and ICU admissions, and decreases hospital costs.


  • Open Access

    Coxiella burnetii Infection in Hemodialysis and Other Vascular Grafts

    by Marcela González-Del Vecchio, Antonio Vena, Maricela Valerio, Mercedes Marin, Eduardo Verde, Patricia Muñóz, Emilio Bouza

    Prosthetic arteriovenous (AV) graft infection is the principal cause of morbidity related to chronic hemodialysis AV graft fistula. Coxiella burnetii is a known pathogen that causes fever, pneumonia, and intravascular infections with the limitation of negative cultures. Herein, we report the first case of a patient who presented to the emergency department of our hospital with a prosthetic hemodialysis AV graft infection due to Coxiella burnetii. We also performed a literature search with PubMed to identify studies reporting cases of Coxiella burnetii vascular graft infection. Overall, we reviewed 15 cases of vascular graft infection, including ours. We found a high prevalence of male patients (87%); mean age ± standard deviation (SD) of the entire population was 60.4 ± 9.6 years. The dacron infrarenal aortic and the aortobifemoral bypass were the most common involved grafts. The early diagnosis of infection due to Coxiella burnetii was done by serology or with polymerase chain reaction (PCR), in 12 and 3 cases, respectively. All patients underwent partial or complete resection of the infected grafts; the most common antibiotic treatment for this entity was doxycycline and hydroxycloroquine. Although this is a relatively rare disease, Coxiella burnetii should be included in the differential diagnosis of all patients who present with infection of an endovascular graft of any nature with an inconclusive etiologic diagnosis.


  • Occult bloodstream infections in adults: a “benign” entity

    by Marcela González-Del Vecchio, Eleonora Bunsow, Carlos Sánchez-Carrillo, Eugenia Garcia Leoni, Marta Rodríguez-Créixems, Emilio Bouza